• Medipost granted CEO Min Ho-sung stock options covering 200,000 common shares on Oct. 29, 2026.
• The options are exercisable from Oct. 30, 2028, through Oct. 29, 2034, with settlement through newly issued shares.
• Total outstanding stock options following the grant cover 745,000 common shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Medipost Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261029000643), on October 29, 2026, and is solely responsible for the information contained therein.